Home › Astrocytoma
Pag-aaral pangklinika para sa Astrocytoma na nagre-recruit sa U.S.
45 pag-aaral para sa Astrocytoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX14 pag-aaral
- Boston, MA13 pag-aaral
- New York City, NY9 pag-aaral
- Chicago, IL9 pag-aaral
- Miami, FL7 pag-aaral
- Philadelphia, PA7 pag-aaral
- Seattle, WA7 pag-aaral
- Columbus, OH6 pag-aaral
- Durham, NC6 pag-aaral
- Washington, DC6 pag-aaral
- San Francisco, CA5 pag-aaral
- Cincinnati, OH5 pag-aaral
- Aurora, CO5 pag-aaral
- Baldwin Park, CA4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Pittsburgh, PA3 pag-aaral
- Kansas City, KS3 pag-aaral
- New Haven, CT3 pag-aaral
- Lexington, KY3 pag-aaral
- Queens, NY3 pag-aaral
- Nashville, TN3 pag-aaral
- Birmingham, AL3 pag-aaral
- Detroit, MI3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- Edison, NJ3 pag-aaral
- Los Angeles, CA3 pag-aaral
- Rochester, MN3 pag-aaral
- St. Louis, MO3 pag-aaral
- Dallas, TX3 pag-aaral
- San Antonio, TX3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- California10 pag-aaral
- Colorado5 pag-aaral
- Connecticut3 pag-aaral
- District of Columbia4 pag-aaral
- Florida9 pag-aaral
- Illinois9 pag-aaral
- Kansas3 pag-aaral
- Kentucky4 pag-aaral
- Massachusetts13 pag-aaral
- Michigan6 pag-aaral
- Minnesota5 pag-aaral
- Missouri4 pag-aaral
- New Jersey3 pag-aaral
- New York9 pag-aaral
- North Carolina7 pag-aaral
- Ohio8 pag-aaral
- Pennsylvania8 pag-aaral
- Tennessee4 pag-aaral
- Texas15 pag-aaral
- Utah4 pag-aaral
- Virginia3 pag-aaral
- Washington8 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Nagre-recruitPhase 2
Edad 18 hanggang 98 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07831369A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05698524SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Nagre-recruitPhase 1/2
Edad 2 hanggang 24 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04923126FearLess in NeuroOncology
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06989086Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594Serial MRI Scans During Radiation Therapy
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04188535Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07215910Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06344130Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07544992Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05417594Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07733674Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT04623931Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06815029Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT07468136A Study of 177Lu-PSMA-617 in People With Gliomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT07223034Loupe-Based Intraoperative Fluorescence Imaging
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT04780009Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT01269853Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.